CM-AT is a medication that helps improve attention, focus, and impulse control in kids with ADHD. It’s a non-stimulant option that works differently than other ADHD meds.
CM-AT is a medication that helps improve attention, focus, and impulse control in kids with ADHD. It’s a non-stimulant option that works differently than other ADHD meds.
Why is CM-AT prescribed for kids with autism?
CM-AT addresses metabolic imbalances found in many kids with autism, aiming to provide a more comfortable digestive experience.
Can CM-AT aid in behavioral improvements?
While CM-AT targets digestion, better gastrointestinal health can indirectly support mood and behavior in some kids.
What's the link between CM-AT and improved life skills?
CM-AT focuses on metabolic balance, which can enhance overall well-being, making life skills training and routines more effective.
Is CM-AT available for use now?
Centanafadine-SR (CM-AT) is a novel, non-stimulant medication for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. It is a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI) that works by increasing levels of these neurotransmitters in the brain. CM-AT is a promising new option for kids with ADHD who don’t respond well to or can’t tolerate stimulant medications.
CM-AT is aimed at enhancing the quality of life for kids with ADHD by improving their ability to concentrate and manage impulses, which can lead to better academic performance and social interactions. Here’s how CM-AT might assist in real-life scenarios:
| Benefit | Impact |
|---|---|
| Improves School Focus | Longer concentration on academic tasks. |
| Enhances Social Interactions | More appropriate participation in groups. |
| Reduces Disruptive Behavior | Leads to a positive learning environment. |
| Supports Emotional Regulation | Better management of frustrations. |
By addressing core ADHD symptoms, CM-AT could significantly help children navigate daily challenges, making it easier for them to succeed academically and socially.
This post was originally published on Sept. 10, 2023. It was updated on April 4, 2024.
